Your browser doesn't support javascript.
loading
Persistent SARS-CoV-2 infection: significance and implications.
Machkovech, Heather M; Hahn, Anne M; Garonzik Wang, Jacqueline; Grubaugh, Nathan D; Halfmann, Peter J; Johnson, Marc C; Lemieux, Jacob E; O'Connor, David H; Piantadosi, Anne; Wei, Wanting; Friedrich, Thomas C.
Afiliação
  • Machkovech HM; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
  • Hahn AM; Department of Epidemiology of Microbial Diseases, School of Public Health, Yale University, New Haven, CT, USA.
  • Garonzik Wang J; Department of Surgery, University of Wisconsin-Madison, Madison, WI, USA.
  • Grubaugh ND; Department of Epidemiology of Microbial Diseases, School of Public Health, Yale University, New Haven, CT, USA.
  • Halfmann PJ; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
  • Johnson MC; Department of Molecular Microbiology and Immunology, University of Missouri-School of Medicine, Columbia, MO, USA.
  • Lemieux JE; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • O'Connor DH; Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.
  • Piantadosi A; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Wei W; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
  • Friedrich TC; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA. Electronic address: tfriedri@wisc.edu.
Lancet Infect Dis ; 24(7): e453-e462, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38340735
ABSTRACT
SARS-CoV-2 causes persistent infections in a subset of individuals, which is a major clinical and public health problem that should be prioritised for further investigation for several reasons. First, persistent SARS-CoV-2 infection often goes unrecognised, and therefore might affect a substantial number of people, particularly immunocompromised individuals. Second, the formation of tissue reservoirs (including in non-respiratory tissues) might underlie the pathophysiology of the persistent SARS-CoV-2 infection and require new strategies for diagnosis and treatment. Finally, persistent SARS-CoV-2 replication, particularly in the setting of suboptimal immune responses, is a possible source of new, divergent virus variants that escape pre-existing immunity on the individual and population levels. Defining optimal diagnostic and treatment strategies for patients with persistent virus replication and monitoring viral evolution are therefore urgent medical and public health priorities.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos